Filing Details

Accession Number:
0001209191-16-126264
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-07 16:40:27
Reporting Period:
2016-06-07
Filing Date:
2016-06-07
Accepted Time:
2016-06-07 16:40:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1539029 Clearside Biomedical Inc. CLSD Pharmaceutical Preparations (2834) 452437375
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1579466 Rusnanomedinvest Llc 44, Bldg. 1, Krasnobogatyrskaya Street
Moscow 1Z 107076
No No Yes No
1579787 S.a.r.l. Investments Rmi 7, Robert Stumper
Grand Duchy N4 L-2557
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-06-07 1,179,398 $0.00 1,515,167 No 4 C Direct
Common Stock Acquisiton 2016-06-07 42,857 $7.00 1,558,024 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Preferred Stock Disposition 2016-06-07 2,594,677 $0.00 1,179,398 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
Footnotes
  1. Represents shares received upon conversion of shares of Series B Preferred Stock.
  2. Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series B Preferred Stockautomatically converted into 0.454545 shares of the Issuer's common stock. The Series B Preferred Stock had no expiration date.
  3. The Reporting Person is a wholly-owned subsidiary of Rusnano MedInvest LLC ("RMI LLC"). RMI LLC is the beneficiary of the Reporting Person.